News Image

In a market where value is scarce, NASDAQ:HALO offers a refreshing opportunity with its solid fundamentals.

By Mill Chart

Last update: Jan 24, 2025

Uncover the hidden value in HALOZYME THERAPEUTICS INC (NASDAQ:HALO) as our stock screening tool recommends it as an undervalued choice. NASDAQ:HALO maintains a robust financial position and offers an attractive pricing perspective. Let's dig deeper into the analysis.


Undervalued stocks image

Valuation Analysis for NASDAQ:HALO

ChartMill assigns a Valuation Rating to every stock. This score ranges from 0 to 10 and evaluates the different valuation aspects and compares the price to earnings and cash flows, while taking into account profitability and growth. NASDAQ:HALO scores a 9 out of 10:

  • Based on the Price/Earnings ratio, HALO is valued cheaper than 96.99% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of HALO to the average of the S&P500 Index (28.64), we can say HALO is valued slightly cheaper.
  • HALO is valuated reasonably with a Price/Forward Earnings ratio of 11.18.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of HALO indicates a rather cheap valuation: HALO is cheaper than 97.70% of the companies listed in the same industry.
  • HALO is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.51, which is the current average of the S&P500 Index.
  • Based on the Enterprise Value to EBITDA ratio, HALO is valued cheaper than 96.64% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, HALO is valued cheaper than 96.99% of the companies in the same industry.
  • HALO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • HALO has a very decent profitability rating, which may justify a higher PE ratio.
  • HALO's earnings are expected to grow with 32.40% in the coming years. This may justify a more expensive valuation.

How do we evaluate the Profitability for NASDAQ:HALO?

ChartMill's Profitability Rating offers a unique perspective on stock analysis, providing scores from 0 to 10. These ratings consider a wide range of profitability metrics and margins, both in comparison to industry peers and on their own merits. For NASDAQ:HALO, the assigned 7 is a significant indicator of profitability:

  • The Return On Assets of HALO (18.53%) is better than 98.58% of its industry peers.
  • Looking at the Return On Equity, with a value of 86.69%, HALO belongs to the top of the industry, outperforming 99.65% of the companies in the same industry.
  • HALO has a Return On Invested Capital of 19.23%. This is amongst the best in the industry. HALO outperforms 98.05% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for HALO is above the industry average of 13.83%.
  • The 3 year average ROIC (17.78%) for HALO is below the current ROIC(19.23%), indicating increased profibility in the last year.
  • With an excellent Profit Margin value of 41.43%, HALO belongs to the best of the industry, outperforming 98.76% of the companies in the same industry.
  • With an excellent Operating Margin value of 50.35%, HALO belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • The Gross Margin of HALO (82.09%) is better than 87.26% of its industry peers.

ChartMill's Evaluation of Health

ChartMill assigns a Health Rating to every stock. This score ranges from 0 to 10 and evaluates the different health aspects like liquidity and solvency, both absolutely, but also relative to the industry peers. NASDAQ:HALO scores a 7 out of 10:

  • HALO has an Altman-Z score of 4.58. This indicates that HALO is financially healthy and has little risk of bankruptcy at the moment.
  • HALO has a better Altman-Z score (4.58) than 79.29% of its industry peers.
  • HALO has a debt to FCF ratio of 3.83. This is a good value and a sign of high solvency as HALO would need 3.83 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 3.83, HALO belongs to the best of the industry, outperforming 94.16% of the companies in the same industry.
  • A Current Ratio of 10.36 indicates that HALO has no problem at all paying its short term obligations.
  • The Current ratio of HALO (10.36) is better than 81.59% of its industry peers.
  • HALO has a Quick Ratio of 9.15. This indicates that HALO is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Quick ratio value of 9.15, HALO is doing good in the industry, outperforming 77.35% of the companies in the same industry.

Evaluating Growth: NASDAQ:HALO

ChartMill assigns a Growth Rating to every stock. This score ranges from 0 to 10 and evaluates the different growth aspects like EPS and Revenue, both in the past as in the future. NASDAQ:HALO scores a 9 out of 10:

  • The Earnings Per Share has grown by an impressive 55.33% over the past year.
  • Measured over the past years, HALO shows a very strong growth in Earnings Per Share. The EPS has been growing by 45.64% on average per year.
  • HALO shows a strong growth in Revenue. In the last year, the Revenue has grown by 21.36%.
  • HALO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 40.42% yearly.
  • Based on estimates for the next years, HALO will show a very strong growth in Earnings Per Share. The EPS will grow by 25.94% on average per year.
  • The Revenue is expected to grow by 16.59% on average over the next years. This is quite good.

More Decent Value stocks can be found in our Decent Value screener.

Check the latest full fundamental report of HALO for a complete fundamental analysis.

Keep in mind

This article should in no way be interpreted as advice. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.

Back

HALOZYME THERAPEUTICS INC

NASDAQ:HALO (1/23/2025, 9:09:06 PM)

Premarket: 54.82 -0.81 (-1.46%)

55.63

+0.35 (+0.63%)

Follow us for more